Brief: ABVC Biopharma Enters Into Term Sheet To License Global Rights Of CNS Drugs with Indications of MDD and ADHD To AiBtl Biopharma

ABVC Biopharma

26/10/2023 14:13

Oct 26 (Reuters) - ABVC Biopharma Inc  ABVC.O :
    * ABVC BIOPHARMA ENTERED INTO A TERM SHEET TO LICENSE GLOBAL
RIGHTS OF CNS DRUGS WITH THE INDICATIONS OF MDD AND ADHD TO
AIBTL BIOPHARMA AT THE VALUATION OF $667 MILLION
    * ABVC BIOPHARMA INC - POTENTIAL LICENSE WILL COVER LICENSED
PRODUCTS' CLINICAL TRIAL, REGISTRATION, MANUFACTURING, SUPPLY,
AND DISTRIBUTION RIGHTS

Source text for Eikon:  ID:nGNXbk52VV 
Further company coverage:  ABVC.O 

 ((Reuters.Briefs@thomsonreuters.com))